Recombinant vaccines and the development of new vaccine strategies.
about
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived VectorsSafety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a modelChallenges in the research and development of new human vaccines.HIV vaccines: a brief overview.Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.Pneumonia and Streptococcus pneumoniae vaccine.Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model.Targeting Type IV Secretion System Proteins to Combat Multidrug-Resistant Gram-positive Pathogens.Recent mass spectrometry-based techniques and considerations for disulfide bond characterization in proteins.Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.Cross-protection conferred by immunization with an rOmpH-based intranasal fowl cholera vaccine.Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4+ or CD8+ T cell activation.Microcrystalline Cellulose for Delivery of Recombinant Protein-Based Antigen against Erysipelas in Mice.Antibody and cytokine response to Cystoisospora suis infections in immune-competent young pigs.Human-applicable dendrigraft poly-l-lysine-based nanoparticle-coated Plasmodium yoelii-transamidase DNA vaccine is immunogenic and protective as the polyethylenimine-based formulationNanoparticle Vaccines Against Infectious Diseases
P2860
Q26746915-D63F38CC-1116-486D-ABD0-CB6727B0F8ABQ36294004-FA45EC82-EC48-4B39-ADD6-A45377C5270DQ38096300-8D8FB8AE-93A1-4489-B2C9-9FB37CCE470DQ38210557-4942884E-193A-4758-ABCE-52AD26217808Q38678186-FFAEE36A-E7F3-44D6-A545-891BAAC19B84Q38970262-8CC6E93F-6A46-4C79-8013-CC5269EF724FQ39452604-D288B939-5BB9-40C9-8F51-B4C70613599BQ39574503-EF7FD137-0FEA-4E81-9098-7413E35B64BEQ40070485-00DC0CA7-52A6-47AF-89F9-FD5F15EF4B67Q47277949-77D22AB7-FA95-4BA0-A2C6-F9430C7F2827Q47433828-C96E1A0D-DEE2-4892-B807-E68A28A9CA64Q51049621-F943AB58-55F2-4659-923F-FEE775D26432Q52595182-5974C065-340D-44DA-8103-E78F750C89F7Q55169959-241AAC0D-95FD-4D77-8D7F-B218CBF3B43AQ55501344-168D58FA-6362-4466-BF7D-DAD7E8AA4E43Q55561967-D3CB555E-1934-4461-8690-834E77EB9A8CQ57261130-7BA22E45-BED4-4F79-A738-56B8C13F4F32Q58583890-788741F9-AEB5-4672-99AE-463C926EEC66
P2860
Recombinant vaccines and the development of new vaccine strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant vaccines and the development of new vaccine strategies.
@en
Recombinant vaccines and the development of new vaccine strategies.
@nl
type
label
Recombinant vaccines and the development of new vaccine strategies.
@en
Recombinant vaccines and the development of new vaccine strategies.
@nl
prefLabel
Recombinant vaccines and the development of new vaccine strategies.
@en
Recombinant vaccines and the development of new vaccine strategies.
@nl
P2860
P50
P1476
Recombinant vaccines and the development of new vaccine strategies
@en
P2093
I P Nascimento
L C C Leite
P2860
P304
P356
10.1590/S0100-879X2012007500142
P407
P577
2012-09-06T00:00:00Z